TABLE 1.
Summary of features of chronically EEHV-infected elephants evaluated in these studies
| Elephant | Location | Sex,a age (yr) | Origin (at birth) | Evidence of:b |
||
|---|---|---|---|---|---|---|
| EEHV1A | EEHV1B | EEHV4/5 | ||||
| HZI-1 (Thai) | Houston | M, 52 | Wild | + | + | + |
| HZI-2 (Methai) | Houston | F, 49 | Wild | + | + | + |
| HZI-3 (Shanti) | Houston | F, 27 | Captive | + | + | + |
| HZI-4 (Tess) | Houston | F, 37 | Wild | + | + | + |
| HZI-5 (Tucker) | Houston | M, 11 | Captive | + | + | + |
| HZI-6 (Baylor) | Houston | M, 7 | Captive | − | + | + |
| HZI-7 (Tupelo) | Houston | F, 7 | Captive | + | + | + |
| HZI-8 (Duncan) | Houston | M, 4 | Captive | − | + | + |
a
M, male; F, female.
b
Evidence of prior viremia or shedding associated with the EEHV species. +, evidence; −, no evidence.